Abacavir Sulfate; Lamivudine Patent Expiration
Abacavir Sulfate; Lamivudine is Used for treating HIV infection. It was first introduced by Viiv Healthcare Co
Abacavir Sulfate; Lamivudine Patents
Given below is the list of patents protecting Abacavir Sulfate; Lamivudine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Epzicom |
US6294540 (Pediatric) | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Nov 14, 2018
(Expired) | Viiv Hlthcare |
Epzicom | US6294540 | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
May 14, 2018
(Expired) | Viiv Hlthcare |
Epzicom |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
Epzicom |
US6417191 (Pediatric) | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Sep 28, 2016
(Expired) | Viiv Hlthcare |
Epzicom | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
Epzicom | US6417191 | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Mar 28, 2016
(Expired) | Viiv Hlthcare |
Abacavir Sulfate; Lamivudine's Family Patents

Explore Our Curated Drug Screens
Abacavir Sulfate; Lamivudine Generic API Manufacturers
Several generic applications have been filed for Abacavir Sulfate; Lamivudine. The first generic version for Abacavir Sulfate; Lamivudine was by Teva Pharmaceuticals Usa and was approved on Sep 29, 2016. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Apr 16, 2025.
Given below is the list of companies who have filed for Abacavir Sulfate; Lamivudine generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Mar 28, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Nov 15, 2018 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Mar 28, 2017 |
4. CIPLA
Cipla Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Cipla.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG
(reference standard) | tablet | Prescription | ORAL | AB | Mar 28, 2017 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
5. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Apr 16, 2025 |
6. LAURUS
Laurus Labs Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Laurus.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Jul 25, 2022 |
Manufacturing Plant Locations New
Laurus's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Laurus as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
7. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Prescription | ORAL | AB | Dec 19, 2024 |
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Sep 29, 2016 |
9. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Abacavir Sulfate; Lamivudine. This eq 600mg base;300mg version comes by the name ABACAVIR SULFATE AND LAMIVUDINE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 600MG BASE; 300MG | tablet | Discontinued | ORAL | N/A | Nov 15, 2018 |